Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Odor Concentration Change Coding in the Olfactory Bulb.

Parabucki A, Bizer A, Morris G, Munoz AE, Bala ADS, Smear M, Shusterman R.

eNeuro. 2019 Feb 27;6(1). pii: ENEURO.0396-18.2019. doi: 10.1523/ENEURO.0396-18.2019. eCollection 2019 Jan-Feb.

2.

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice.

Ridruejo E, Marciano S, Galdame O, Reggiardo MV, Muñoz AE, Adrover R, Cocozzella D, Fernandez N, Estepo C, Mendizabal M, Romero GA, Levi D, Schroder T, Paz S, Fainboim H, Mandó OG, Gadano AC, Silva MO.

Ann Hepatol. 2014 May-Jun;13(3):327-36.

3.

Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir.

Ridruejo E, Marciano S, Galdame O, Reggiardo MV, Muñoz AE, Adrover R, Cocozzella D, Fernandez N, Estepo C, Mendizábal M, Romero GA, Levi D, Schroder T, Paz S, Fainboim H, Mandó OG, Gadano AC, Silva MO.

J Viral Hepat. 2014 Aug;21(8):590-6. doi: 10.1111/jvh.12200. Epub 2013 Nov 4.

PMID:
24188363
4.

Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children.

Lagos RE, Muñoz AE, Levine MM, Lepetic A, François N, Yarzabal JP, Schuerman L.

Hum Vaccin. 2011 May;7(5):511-22. Epub 2011 May 1.

PMID:
21441782
5.

Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines.

Barkho BZ, Munoz AE, Li X, Li L, Cunningham LA, Zhao X.

Stem Cells. 2008 Dec;26(12):3139-49. doi: 10.1634/stemcells.2008-0519. Epub 2008 Sep 25.

6.

[New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C].

Muñoz AE.

Acta Gastroenterol Latinoam. 2007 Jun;37(2):126-33. Spanish. No abstract available.

PMID:
17684944
8.

Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Paladino N, Fainboim H, Theiler G, Schroder T, Muñoz AE, Flores AC, Galdame O, Fainboim L.

J Virol. 2006 Sep;80(18):9144-50.

9.

Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis.

De Biasio MB, Periolo N, Avagnina A, García de Dávila MT, Ciocca M, Goñi J, de Matteo E, Galoppo C, Cañero-Velasco MC, Fainboim H, Muñoz AE, Fainboim L, Cherñavsky AC.

J Clin Pathol. 2006 Apr;59(4):417-23. Epub 2006 Feb 17.

10.

Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children.

Cherñavsky AC, Paladino N, Rubio AE, De Biasio MB, Periolo N, Cuarterolo M, Goñi J, Galoppo C, Cañero-Velasco MC, Muñoz AE, Fainboim H, Fainboim L.

Hum Immunol. 2004 Jul;65(7):683-91.

PMID:
15301856
11.

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.

Terg R, Coronel E, Sordá J, Muñoz AE, Findor J.

J Hepatol. 2002 Dec;37(6):717-22.

PMID:
12445410
12.

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial.

Muñoz AE, Levi D, Podestá A, Gorín JM, González J, Bartellini MA, Munne MS, Cabanne A, Flichman D, Terg R.

Gut. 2000 Mar;46(3):427-31.

13.

Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.

Muñoz AE, Miguez C, Rubio M, Bartellini M, Levi D, Podestá A, Niselman V, Terg R.

Dig Dis Sci. 1999 Apr;44(4):789-95.

PMID:
10219840
14.

El tratamiento kinésico en las afecciones nerviosas de tipo cerebral.

HERMOSILLA TM, MUNOZ AE.

Bol Educ Fis (Santiago). 1945-1946;12:31-8. Undetermined Language. No abstract available.

PMID:
20982993

Supplemental Content

Loading ...
Support Center